Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Canada Pension Plan Investment Board
company
About
Canada Pension Plan Investment Board invests in the contributors and beneficiaries to maximize investment returns.
- 1001 - 5000
Highlights
Details
- Industries
- Financial Services,Impact Investing,Management Consulting,Non Profit,Real Estate
- Founded date
- Jan 1, 1997
- Number Of Employee
- 1001 - 5000
- Operating Status
- Active
- Investor Type
- Government Office,Venture Debt
Our mandate is to invest in the best interests of Canada Pension Plan contributors and beneficiaries and to maximize investment returns without undue risk of loss.We are a professional investment management organization that invests the assets of the Canada Pension Plan not currently needed to pay pension, disability and survivor benefits. Our critical purpose is to help provide a foundation upon which 18 million Canadians build their financial security in retirement.
Investments
Number of Investments
Number of Lead Investments
29
8
Canada Pension Plan Investment Board has made 29 investments. Their most recent investment was on
Dec 19, 2022, when Redaptive raised $200M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 19, 2022
Redaptive
|
Series Unknown | $200M | Energy | Yes |
|
Jul 21, 2022
Meati
|
Series C | $150M | Consumer Goods | — |
|
Jul 11, 2022
Klarna
|
Series Unknown | $800M | E-Commerce | — |
|
Feb 10, 2022
KoBold Metals
|
Series B | $192.50M | Machine Learning | — |
|
Jan 6, 2022
Eikon Therapeutics
|
Series B | $518M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
